Navigation Links
Nutralife Hails New Study’s Findings on SAM-e, Giving Hope to Millions Seeking Joint Relief

Lakewood,NJ (PRWEB) April 04, 2013

The popular supplement S-Adenosyl Methionine, commonly known as SAMe received the highest rating for all supplements in a recent report evaluating the efficacy of many supplements taken for osteoarthritis. Once again this study reiterates the value of SAMe and offers significant hope for the 27 million plus Americans who suffer from osteoarthritis on a daily basis.

In the report released by Arthritis Research UK, a major medical research organization in England, researchers evaluated 31 complementary medicines taken either by mouth or applied to the skin that were found to have quality studies available. Each was scored for effectiveness based on users’ improvements in pain, disability or quality of life on a scale of 1 to 5, with “1” suggesting the lowest degree of efficacy and “5” suggesting the highest. SAMe received a 4, the highest rating of all the supplements for arthritis relief.

“The results of this study are not surprising to us,” stated Abigail Glass, President and Founder of Nutralife Health Products (NHP), a New Jersey based company that has been distributing SAMe supplements for over a decade. “Our customers have constantly been reporting back to us that SAMe has helped rejuvenate their joints, like no other supplement.” According to the Textbook of Natural Medicine (Michael T. Murray, 2006), a total of 21,524 patients with osteoarthritis have utilized SAMe in detailed clinical trials. In double-blind trials, SAMe has demonstrated similar reductions in pain scores and clinical symptoms to those produced by nonsteroidal anti-inflammatory drugs (NSAIDs) and was found to be generally much better tolerated.

“We are pleased that the benefits and scientific evidence of the efficacy of SAMe has been reiterated,” says Ephraim Glass, VP of Marketing at Nutralife Health Products. “Because of the staggering amount of consumers suffering from osteoarthritis, it is important that they are able to make informed decisions about the supplements they purchase.” There are 27 million people in the United States who suffer from osteoarthritis, and the number is on the rise according to a recent CDC report. According to a US government report released in 2013 by the AHRQ (Agency for Healthcare Research and Quality), a division of the National Institute of Health; Osteoarthritis was the most common diagnosis among adults ages 45-84 in 2010.

“We know that SAMe is truly a unique product,” says Sarah Levi, VP of Research and Development at Nutralife Health Products. “SAMe has been around for decades, has been the subject of numerous clinical trials and reviews, and is time and again proven effective.”

Nutralife Health Products introduced SAMe into the United States in the 1990s, and it remains a leading brand in SAMe distribution. NHP’s SAMe is available in 200mg and 400mg doses and contain the trademarked (S)SAMe, Nutralife’s proprietary SAMe raw material.

Nutralife has always been at the forefront of SAMe research. “We hope that by promoting consumer awareness, many more people will realize the benefits of SAMe,” stated Abigail Glass.

To see the full report by Arthritis Research UK, see the following link:

About NutraLife™ Health Products:

NutraLife™ Health Products (NHP), a women-owned business, was founded in 1996 by two women with one goal: to provide health-conscious individuals with natural, safe, and clinically-proven dietary supplements. NHP features a complete line of vitamins and supplements under the NutraLife™ brand. NutraLife™ SAMe products are among the leading selling SAMe SKU’s in the nutritional supplement category according to IRI, and can be found at prominent retailers such as Walgreens and CVS.

To find out more about Nutralife SAMe, please contact Nutralife Health Products.

Nutralife Health Products

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Nutralife Health Products Inc. Announces Launch of New Website for its Revolutionary Joint Supplement, JointRite
2. New England Journal of Medicine hails new skin cancer drug as greatest advance yet
3. New findings in breast cancer
4. Kessler Foundation scientists present cognitive research findings at MS dual symposium
5. Researchers present new findings for novel pancreatic cancer vaccine
6. Mayo Clinic urologists present findings at American Urological Association Annual Meeting
7. Once-Banned Bird Flu Study Yields Sobering Findings
8. Columbus Allergist Dr. Summit Shah Discusses Recent Findings on Food Allergies and Exercise-Induced Anaphylaxis
9. Relief for Migraine Sufferers as The Life House Offers New Findings, Free Consults
10. New findings by GW researcher break tanning misconceptions: There is no such thing as a safe tan
11. MRI findings shed light on multiple sclerosis
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... ... additions to its industry-leading suite of automated breast density assessment and enterprise ... (RSNA) meeting, November 29-December 4, 2015 (South Hall booth #2377). Volpara’s quantitative ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... Kreithen”), one of the leading plastic surgery practices in Florida, is proud to ... to consult for surgical innovations giant Ethicon Inc., a Johnson & Johnson Company. ...
(Date:11/30/2015)... ... 30, 2015 , ... The successful filing of an Investigational New Drug application ... important to this key industry segment, Regis Technologies has decided to sponsor and participate ... at 11am EST. , Federal law does not allow new drugs to cross state ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... assets of DataTrade Solutions Inc., a Healthcare IT consulting, development and support company. ... programming and technical experience available within DataTrade to extend the services currently provided ...
(Date:11/30/2015)... ... November 30, 2015 , ... GKhair & Tibolli team members and ... Beauty Show held on November 8th and 9th at the Puerto Rico Convention Center, ... artists, renowned beauticians and top of the line fashion journalists. The San Juan Beauty ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015 Cumberland Pharmaceuticals (CPIX), today announced that ... on December 3, 2015. TIME: 3:15p.m. ET ... ET LINK: --> DATE: ... --> --> ... are invited to ask the company questions in real-time - ...
(Date:11/30/2015)... -- Varian Medical Systems (NYSE: VAR ) has signed a ... Hospitals Group, the largest hospital chain in India ... in the country. The MoU was signed by Dr. K. ... Kakkar , Varian,s India managing director, in ... , Varian intends to deploy its Access to Care program by ...
(Date:11/30/2015)... and BOSTON , November 30, 2015 ... develop potential new medicines directed at up to 10 ... --> PFE ) to research and develop ... protein-coupled receptor (GPCR) targets across multiple therapeutic areas. ... drug discovery and development company and wholly-owned subsidiary of ...
Breaking Medicine Technology: